Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.7 USD | -0.19% | +2.14% | -6.72% |
May. 02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.72% | 9.39B | |
-3.54% | 184B | |
-0.58% | 109B | |
-2.74% | 68.37B | |
+4.84% | 51.56B | |
+10.40% | 44.69B | |
+3.26% | 41.49B | |
+2.87% | 26.75B | |
+4.61% | 26.7B | |
+11.94% | 25.68B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 Revenue $178.2M, vs. Street Est of $164M